Hacohen Y, Dlamini N, Hedderly T, Hughes E, Vincent A, Lim ML. N-Methyl – D-Aspartate receptor antibody-associated movement disorder without encephalopathy. Developmental Medicine & Child Neurology, 2014; 56: 190-193.
Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnage M, Alber M, Geider K, Laube B, Schwake M, Finsterwalder K, Franke A, Schilhabel M, Jähn JA, Muhle H, Boor R, Van Paesschen W, Caraballo R, Fejerman N, Weckhuysen S, De Jonghe P, Larsen J, Møller RS, Hjalgrim H, Addis L, Tang S, Hughes E, Pal DK, Veri K, Vaher U, Talvik T, Dimova P, López RG, Serratosa JM, Linnankivi T, Lehesjoki A-E, Ruf S, Wolff M, Buerki S, Wohlrab G, Kroell J, Datta AN, Fiedler B, Kurlemann G, Kluger G, Hahn A, Haberlandt DE, Kutzer C, Sperner J, Becker F, Weber YG, Feucht M, Steinböck H, Neophythou B, Ronen GM, GruberSedlmayr U, Geldner J, Harvey RJ, Hoffmann P, Herms S, Altmüller J, Toliat MR, Thiele H, Nürnberg P, Wilhelm C, Stephani U, Helbig I, Lerche H, Zimprich F, Neubauer BA, Biskup S & von Spiczak S. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nature Genetics, 2013; 45: 1067-1072
McTague A, Appleton R, Avula S, Cross JH, King MD, Jacques TS, Bhate S , Cronin A Curran A, Desurkar A, Farrell MA, Hughes E, Jefferson R, Lascelles K, Livingstone J, Meyer E, McLellan A, Poduri A, Scheffer IE, Spinty S, Kurian MA, Kneen R - Migrating Partial Seizures of Infancy (MPSI): Expansion of the Electroclinical, Radiological and Pathological Disease Spectrum. Brain, 2013; 136: 1578-1591.
Alkufri F, Harrower T, Rahman Y, Hughes E, Mundy M, Knibb JA, Moriaty J, Connor S, Samuel M, Molybdenum co-factor deficiency presenting with a parkinsonism-dystonia syndrome. Movement Disorders, 2013; 28: 399-401. Hacohen Y, Wright S, Waters P, Agrawal S, Carr L, Cross H, De Sousa C, DeVile C, Fallon P, Gupta R, Hedderly T, Hughes E, Kerr T, Lascelles K, Lin JP, Philip S, Pohl K, Prabahkar P, Smith M, Williams R, Clarke A, Hemingway C, Wassmer E, Vincent A, Lim ML. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes inpatients with or without antibodies to known central nervous system autoantigens. Journal of Neurolology, Neurosurgery and Psychiatry. 2013 84:748- 55.
Tang, S., Lin, J. P., Hughes, E., Siddiqui, A., Lim, M. and Lascelles, K. Encephalopathy and SCN1A mutations. Epilepsia, (2011), 52: e26–e30
Ackers R, Besag F, Hughes E, Squier W, Murray M, Wong ICK. Mortality rates and causes of death in children with epilepsy prescribed antiepileptic drugs: a retrospective cohort study using the UK General Practice Research database. Drug Safety, 2011;34:403-413.
Martin Miguel MC, Garcia Seoane JJ, Valentin A, Hughes E, Selway R, Polkey CE, Alarcon G. EEG latency analysis for hemispheric localisation in Landau Kleffner syndrome. Clinical Neurophysiology 2011; 122: 244-252.
Gika AD, Hughes E, Goyal S, Sparkes M, Lin J-P. Trihexyphenidyl for acute life-threatening episodes due to a dystonic movement disorder in Rett syndrome. Movement Disorders, 2010; 25:385-404.
Hughes E, Lax-Pericall T. Episodic dyscontrol. Journal of Pediatric Neurology: Special issue: non-epileptic paroxysmal disorders. 2010; Vol 8 (1) 119-121.
Besag FM, Hughes EF. Paroxysmal disorders in infancy: a diagnostic challenge. Developmental medicine and Child Neurology 2010; 52:1014-1020.